Generic drug maker Mylan Inc. is moving its stock exchange listing to the Nasdaq market from the New York Stock Exchange, effective Dec. 29.
119930
Drug maker Mylan to move to Nasdaq
102525
Nasdaq OMX receives SEC approval for new low price listings Market
20585
Facebook added to Nasdaq-100 index;
40683
Misys to commence a buy back of its shares in the market
109404
Nasdaq Dubai changes opening hours
78929
Drug stocks zigzag;
154583
Nasdaq OMX Group completes acquisition of Boston Stock Exchange
101436
Igesund to go to market
51477
Dow Jones makes two changes
159178
Max & Erma's receives NASDAQ
19590
Generex Biotechnology comments on recent trading activity
70923
Nymex to change margins for copper futures contracts
45833
New York pharmaceutical company to open division this summer
170591
NiSource says it will sell up to $400 million in stock
85156
Drug stocks follow market lower;
20039
Jpm shifting some swaps to subsidiary
171432
Dow Chemical to rejig business structure